Veterinary and Biomedical Sciences, School of
Jay Reddy Publications
Accessibility Remediation
If you are unable to use this item in its current form due to accessibility barriers, you may request remediation through our remediation request form.
Document Type
Article
Date of this Version
2015
Citation
Published in final edited form as: Scandinavian Journal of Immunology 2015 November ; 82(5): 399–408. doi:10.1111/sji.12344.
PMCID: PMC4610346 ;NIHMSID: NIHMS726723 ; PMCID:PMC4610346 http://www.ncbi.nlm.nih.gov/pubmed/26207337
Abstract
The advent of major histocompatibility complex (MHC) tetramer technology has been a major contribution to T cell immunology, because tetramer reagents permit detection of antigen-specific T cells at the single-cell level in heterogeneous populations by flow cytometry. However, unlike MHC class I tetramers, the utility of MHC class II tetramers has been less frequently reported. MHC class II tetramers can be used successfully to enumerate the frequencies of antigen-specific CD4 T cells in cells activated in vitro, but their use for ex vivo analyses continues to be a problem, due in part to their activation dependency for binding with T cells. To circumvent this problem, we recently reported the creation of a new generation of reagents called MHC class II dextramers, which were found to be superior to their counterparts. In this review, we discuss the utility of class II dextramers vis-a-vis tetramers, with respect to their specificity and sensitivity, including potential applications and limitations.
Comments
Copyright 2015 The Foundation for the Scandinavian Journal of Immunology; published by John Wiley & Sons. PubMed Central version used by permission.